Clinical Trial Imaging Market Growth, Trend, Outlook And Analysis 2024-2033

The Business Research Company recently released a comprehensive report on the Global Clinical Trial Imaging Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15765&type=smp

According to The Business Research Company's, The clinical trial imaging market size has grown strongly in recent years. It will grow from $1.32 billion in 2023 to $1.44 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increased sales and the distribution of clinical imaging software and services, increased risks of breast cancer, increased healthcare spending, rise in healthcare expenditure results in improved infrastructure, increased research and development spending by the pharmaceutical and biotechnological companies.

The clinical trial imaging market size is expected to see strong growth in the next few years. It will grow to $2.07 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to growing chronic diseases, rising research and development expenditures, an increasing geriatric population, a growing number of clinical studies, and an increasing number of contract research organizations. Major trends in the forecast period include technological advancements enhancing imaging modalities, strategic initiatives by market players to expand capabilities and offerings, adoption of imaging-based approaches in drug development, advancements in molecular imaging and AI-driven analysis, and product innovation.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report

Market Drivers and Trends:

The growing prevalence of cancer cases is expected to propel the growth of the cell and gene therapy contract development and manufacturing organization (CDMO) market going forward. Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells in the body. The growing prevalence of cancer cases is due to aging populations, lifestyle changes, environmental exposures, and improved detection methods. Cell and gene therapy contract development and manufacturing organization (CDMO) helps reduce cancer prevalence by developing and manufacturing innovative, targeted treatments that enhance efficacy and patient outcomes. For instance, in October 2022, according to Macmillan Cancer Support, a UK-based charitable organization, the estimated number of people living with cancer in the UK is projected to increase from 3 million in 2022 to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the growing prevalence of cancer cases drives the growth of the cell and gene therapy contract development and manufacturing organization (CDMO) market.

Major companies operating in the clinical trial imaging market are developing cloud-based image tools to provide better solutions and improve the efficiency of clinical trials. Cloud-based imaging tools are software applications and platforms that utilize cloud computing technology to store, manage, and analyze medical images. For instance, in March 2023, Clarion, a US-based manufacturer of advanced power distribution systems, launched a cutting-edge cloud-based image viewer tool. This innovative tool offers real-time, on-demand viewing and manipulation of high-resolution images, providing read-quality access to images in near real-time while eliminating manual steps that were previously required. It streamlines the image viewing process, eliminating manual steps and making image accessibility easy, secure and data privacy compliant. The tool offers full-resolution viewing and manipulation capabilities, empowering end users to gain valuable insights into their trial subject.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Koninklijke Philips N.V., Labcorp Drug Development, Icon Plc, PPD Inc., Syneos Health, Charles River Laboratories, Parexel International Corporation, Clario, Medpace Inc., Medidata Solution Inc., Biotelemetry Inc., WIRB-Copernicus Group, ProScan Imaging LLC, Invicro LLC, Perspectum , Radiant Sage LLC, Worldcare Clinical LLC , Intrinsic Imaging LLC, Datatrak Inc., IXICO Plc, Calyx Inc., Resonance Health Ltd., Anagram-ESIC SL

Clinical Trial Imaging Market 2024 Key Insights:

• The clinical trial imaging market size is expected to see strong growth in the next few years. It will grow to $2.07 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%.
• The Rising Prevalence Of Chronic Diseases Fuels Growth In The Clinical Trial Imaging Market
• Innovations In Cloud-Based Image Viewers Drive Efficiency In Clinical Trial Imaging Market
• North America was the largest region in the clinical trial imaging market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=15765&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.